The effect of procaine hydrochloride, an anesthetic known to alter membrane structure, on the induced formation of alkaline phosphatase, a periplasmic enzyme, in Escherichia coli was investigated. Procaine hydrochloride specifically arrested the appearance of active alkaline phosphatase while permitting the induction of another enzyme, (8-galactosidase, which is internally localized. Evidence has been obtained to show that procaine hydrochloride does not arrest synthesis of inactive monomer subunits of the enzyme, indicating that the drug interferes in the conversion of monomer subunits to an active dimer enzyme.
The effect of procaine hydrochloride, an anesthetic known to alter membrane structure, on the induced formation of alkaline phosphatase, a periplasmic enzyme, in Escherichia coli was investigated. Procaine hydrochloride specifically arrested the appearance of active alkaline phosphatase while permitting the induction of another enzyme, (8-galactosidase, which is internally localized. Evidence has been obtained to show that procaine hydrochloride does not arrest synthesis of inactive monomer subunits of the enzyme, indicating that the drug interferes in the conversion of monomer subunits to an active dimer enzyme.
The pathway of alkaline phosphatase formation in Escherichia coli cells is believed (12) to consist of the following sequence of events: (i) synthesis of the inactive monomer protein in the cytoplasm; (ii) transport of monomer subunits through the cell membrane; and (iii) their assembly into active dimer form in the periplasmic region. In our earlier paper (19) , it was reported that phenethyl alcohol, an agent believed to alter the cell membrane structure (15) , inhibits the formation of active alkaline phosphatase at the dimerization level. Possibly, this inhibition was brought about by the primary action of phenethyl alcohol on the cell membrane. It was, hence, of interest to study whether other membrane-affecting agents similarly interfere with the induction of alkaline phosphatase.
In the present study, it was found that procaine hydrochloride, a local anesthetic known to interact with the cellular membrane (8, 9) , also specifically inhibited the formation of active alkaline phosphatase while allowing the synthesis of inactive monomer subunits of the enzyme.
MATERIALS AND METHODS Bacterial strain. E. coli 113-3, an auxotrophic strain that requires either vitamin B,2 or methionine for its growth and is inducible for alkaline phosphatase synthesis, was used throughout the investigation. The auxotrophic mutant was isolated by Davis and Mingioli (2) with constant shaking in phosphate-deficient medium of the following basal composition (per liter): sodium citrate, 0.56 g; (NH4)2SO4, 2.0 g; MgSO4 * 7H20, 0.05 g; glucose, 5.0 g; DL-aspartic acid, 1.0 g; and DL-methionine, 0.05 g. To this medium, Tris was added to a final concentration of 0.1 M, and the pH was adjusted to 7.4 with hydrochloric acid.
This medium, referred to as A-Pi medium, was used to derepress synthesis of alkaline phosphatase and was similar to Torriani's A-P medium (16) .
The procedure for measuring the amounts of alkaline phosphatase, by formation of p-nitrophenol from p-nitrophenylphosphate, was essentially according to Torriani (16) . One unit of enzyme is the amount that produces an increase in absorbance at 420 nm of 0.01 in 1 min measured in a cuvette of 1-cm path length.
Induction of I3-galactosidase synthesis. To induce ,3-galactosidase synthesis, isopropyl-,S-n-thiogalactopyranoside (IPTG) was added to A-Pi medium at a final concentration of 1 x 10-3 M, and the enzyme formed was measured by the method of Horiuchi et al. (6) (13) . The mixture was incubated under in vitro conditions that favor dimerization of the inactive monomer subunits to active alkaline phosphatase (13) , and then it was incubated with Pronase (0.2 mg/ml) at 45°C for 5 h (4). The Pronase-digested sample was dialyzed against 0.02 M Tris-hydrochloride buffer, pH 7.4, containing 0.01 M MgSO4 at 2°C overnight. The dialyzate containing Pronase-resistant material, in a total volume of 3.8 ml, was passed through a diethylaminoethyl (DEAE)-cellulose column (12 by 2.5 cm) previously equilibrated with 0.01 M Trishydrochloride buffer, pH 7.4, containing 0.001 M MgSO4 (buffer E). Elution was carried out with a 250-ml linear gradient of NaCl (0 to 0.2 M) in buffer E (17) . Eluate was collected in 5-ml fractions in which enzyme activity was determined. To determine the radioactivity incorporated into proteins, portions of the fractions were processed on Whatman no. 3 filter paper strips as described above.
Polyacrylamide gel electrophoresis. The enzyme solution was concentrated by lyophilization, and the concentrate was divided into fractions containing about 25 to 40 ,og of protein each. They were subjected to polyacrylamide gel electrophoresis using 7.5% gels (0.6 by 7 cm) and Tris-glycine buffer of pH 8.3 by the method of Davis (3) . At the end of a 2.5-h run, protein in the gel was stained by 1% amido black in 7% acetic acid, and enzyme activity was detected by the method of Saini and Done involving the immersion of gel in a solution containing 0.5% each CaCl2, MgSO4, and ,B-glycerophosphate as well as 2.0% barbitone (10) . For radioactivity determinations, gels were cut into 2-mm slices that were taken into separate vials and dissolved in 0.6 ml of H202 at 600C.
Measurement of radioactivity. The radioactivity in proteins precipitated on Whatman no. 3 filter paper strips was determined by a scintillator containing 0.5% 2,5-diphenyloxazole in toluene. The radioactivity in H202-digested gel slices was determined with a scintillator containing 0.5% 2,5-diphenyloxazole and 10% naphthalene in 1,4-dioxane. Radioactive counts were determined in a Beckman LS-100 liquid scintillation counter. The counting efficiencies for 14C and 3H were, respectively, 90% and 50%.
Materials. Tris, p-nitrophenylphosphate, o-nitrophenyl-3-D-galactopyranoside, puromycin, and DEAE-cellulose (anion exchanger) were obtained from Sigma Chemical Co.; IPTG was from Mann Research Laboratories, Inc.; and Pronase (B-grade) was from Calbiochem, La Jolla, Calif. Procaine hydrochloride was purchased from Hoechst Pharmaceuticals, Bombay, India; purified E. coli alkaline phosphatase (type III) preparation was a kind gift from Sigma.
[14C]leucine (47.9 mCi/mmol) and [3H]leucine (7,000 mCi/mmol) were obtained from the Isotope Division of this research center.
RESULTS
Increasing concentrations of procaine hydrochloride in the medium progressively suppressed induction of alkaline phosphatase synthesis in E. coli cells during incubation in A-Pi medium (Fig. 1) . The drug inhibited formation of active enzyme by nearly 60% at a concentration of 0.2% and by about 90% at a 0.5% concentration. There was complete inhibition of active enzyme formation at a 0.55% (i.e., 20 mM) concentration. The induction of 8-galactosidase, a cytoplasmic enzyme, and the general protein synthesis, as measured by [14C]leucine incorporation into proteins, were found to be unaffected at this concentration of procaine hydrochloride in the medium ( Fig. 2 and 3 , respectively). When procaine hydrochloride was removed from the medium, formation of active enzyme was resumed to the normal level (Fig. 4) , showmg that the drug's presence reversibly inhibits alkaline phosphatase synthesis. A significant increase in enzyme activity was observed when cells that were preincubated for 1 h in procaine hydrochloride-containing A-P1 medium were transferred to fresh A-P1 medium devoid of procaine hydrochloride but containing puromycin (Table 1) (4) . No such increase in enzyme activity was observed if cells were preincubated for 1 h in a medium containing puromycin in addition to procaine hydrochloride. These results suggest the possibility that procaine hydrochloride may not inhibit the de novo synthesis of alkaline phosphatase protein (in the form of inactive monomer subunits) but may arrest its subsequent conversion to active enzyme (dimer form). The increase in enzyme activity after removal of procaine hydrochloride from the medium may be due to dimerization of the accumulated subunits. (18) . The product, after in vitro dimer-promoting incubation (see above), was chromatographed on the DEAE-cellulose column. Unlike most proteins ofE. coli, including alkaline phosphatase monomers, the dimers are quite resistant to degradation by Pronase (7). This property helped to purify the radioactively labeled phosphatase dimer. The cell-free extract was incubated with Pronase, before or after in vitro dimer-promoting incubation, and then subjected to DEAEcellulose column chromatography. Pronase-resistant material obtained after dimer-promoting incubation showed a major peak of radioactivity that coincided with the enzyme activity peak (Fig. 5a) , whereas Pronase-resistant material obtained before dimer-promoting incubation did not exhibit any radioactivity peak at the dimer enzyme position (Fig. 5b) . The protein from the radioactivity peak in Fig. 5a was further subjected to polyacrylamide gel electrophoresis to ascertain whether the radioactivity was indeed due to the labeled dimer enzyme. The electrophoretic pattern (Fig. 6) showed a single radioactivity peak, which appeared at the same position as that of the enzyme activity band on the gel, clearly indicating that the enzyme was radioactive. This finding would imply that the cell-free extract contained radioactive monomer protein that, on in vitro dimer-promoting incubation, was converted into radioactive dimer enzyme. These experiments thus furnish strong evidence for the supposition that monomer subunits of alkaline phosphatase are synthesized in bacterial cells in the presence of procaine hydrochloride.
The extent of alkaline phosphatase dimer protein formed in E. coli incubated for 1 h in APi medium containing [3H]leucine was determined in a separate experiment under normal conditions (i.e., in the absence of procaine hydrochloride). The cell-free extract of these cells was treated with Pronase and then subjected to DEAE-cellulose chromatography without any prior dimer-promoting incubation. The results, illustrated in Fig. 7 , show the labeling of dimer enzyme. To determine the magnitude of monomer subunit accumulation in the presence of procaine hydrochloride, the label appearing in the radioactivity peak from Fig. 5a was compared with that of the radioactivity peak from of monomer protein accumulation in procaine hydrochloride-treated cells appears to be nearly 70% of the dimer enzyme formed under normal conditions. Failure to get levels of monomer subunits during procaine hydrochloride treatment comparable to those of dimer enzyme could be due to the monomer subunits' instability compared with the dimer enzyme (11) .
To understand the mechanism by which procaine hydrochloride could interfere with transforming inactive subunits of the enzyme to active enzyme, dimerization of purified enzyme .U monomers was examined in an in vitro system (13) in the presence of procaine hydrochloride.
The reactivation of monomer subunits to active dimer enzyme in the presence of 20 mM procaine hydrochloride was found to be nearly 87% of that occurring in the absence of this drug (Fig. 8) , indicating that procaine hydrochloride does not have any significant inhibitory action on the dimerization step per se. DISCUSSION Our earlier studies (19) indicated that phenethyl alcohol, a bacterial cell membrane-affecting agent, inhibits formation of active alkaline phosphatase in E. coli by preventing the conversion of inactive monomer subunits to active dimer enzyme. The results described above indicate that another chemical that also structurally alters the cell membrane similarly inter- in absence of procaine hydrochloride for 1 h was subjected to Pronase treatment. To the Pronase-resistant fraction (after dialysis) was added purified, unlabeled alkaline phosphatase, and the mixture was chromatographed. Results of the incorporation experiments of amino acid precursor into alkaline phosphatase protein suggest that procaine hydrochloride has no inhibitory effect on the de novo synthesis of the enzyme protein. In the absence of this chemical, the radioactive amino acid is predominantly incorporated into dimer enzmne protein; whereas, in its presence, the amino acid is solely incorporated into monomer enzyme protein, whereas, in its presence, the amino acid is that procaine hydrochloride allows synthesis of the enzyme monomer subunits but interferes with their conversion to active dimer enzyme.
Local anesthetics, including procaine hydrochloride, are known to interact with cellular membranes, leading to various changes in membrane characteristics (5) . Accorxling to Shanes (14) , these agents are the stabilizers that alter permeability characteristics of living membrane by adding their own bulk to the lipoid molecules of membrane, thereby causing an increased molecular packing. The basis for the present procaine hydrochloride-caused block in active alkaline phosphatase formation may, therefore, be the maiettion of structural alterations in the bacterial cell membrane. Inhibition of active enzyme formation can arise as a result of either interference with the passage of monomer subunits through the cytoplasmic membrane or prevention of the dimerization event itself in the periplasmic region. In an in vitro system, phenethyl alcohol inhibited the dimerization step considerably (19) . In the present studies, however, procaine hydrochloride hardly exhibited any inhibitory effect on the in vitro dimerization (Fig. 8) . It seems, therefore, more probable that structural alterations in the cell membrane induced by procaine hydrochloride may impair transport of inactive alkaline phosphatase monomer protein to the periplasmic region.
LITERATURE CITED
